ENROLLING BY INVITATIONN/A

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

This study collects information to implement MammoScreen for Breast Cancer Screening and Referrals. MammoScreen is a risk assessment questionnaire that identifies individuals at average and increased risk for breast cancer and guides their screening decisions.

Sponsor

OHSU Knight Cancer Institute

Enrollment

1,141 participants

Sites

1 locations

Start Date

September 2022

Completion

April 2025

Breast CarcinomaElectronic Health Record ReviewInterviewMedia Intervention

Enrollment & Timeline

ENROLLING BY INVITATION

Target enrollment (estimated)

Target N

1,141

participants

Sites

locations

Duration

3.9 years

total trial span

Rate

pts/month needed

Sep 2022Month 46 of 47Apr 2025

98% of trial timeline elapsed1 months to primary endpoint

At 1 sites, each site needs to enroll approximately 24.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Uptake of MammoScreen

Up to 5 years

Defined as the proportion of women who enroll and use MammoScreen. Proportions of invitations for newly eligible women and uptake of MammoScreen during the maintenance period, overall and by clinical team, will be characterized along with 95% exact confidence intervals.

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Fetching protocol from ClinicalTrials.gov…

ENROLLING BY INVITATIONN/A

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Sponsor

OHSU Knight Cancer Institute

Enrollment

1,141 participants

Sites

1 locations

Start Date

September 2022

Completion

April 2025

Breast CarcinomaElectronic Health Record ReviewInterviewMedia Intervention

Enrollment & Timeline

ENROLLING BY INVITATION

Target enrollment (estimated)

Target N

1,141

participants

Sites

locations

Duration

3.9 years

total trial span

Rate

pts/month needed

Sep 2022Month 46 of 47Apr 2025

98% of trial timeline elapsed1 months to primary endpoint

At 1 sites, each site needs to enroll approximately 24.0 patients/month to hit the enrollment target on schedule.

Enrollment target is estimated. ClinicalTrials.gov does not provide real-time enrollment progress.

View on ClinicalTrials.gov

Ask AI

Primary Outcomes

Uptake of MammoScreen

Up to 5 years

Ask AI

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

No linked publications found in PubMed

PubMed/NCBI (daily updates) FDA FAERS (quarterly updates) WHO ICTRP (weekly updates)

Ask AI

Eligibility

Min Age

40 Years

Max Age

74 Years

Sex

female

Healthy Volunteers

Yes

View full criteria

Inclusion Criteria:

* Women between the ages of 40 and 74
* Enrolled in MyChart
* Able to read English

Exclusion Criteria:

* Personal history of breast or ovarian cancer
* Currently Pregnant
* Currently in Hospice

Ask AI

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals

Enrollment & Timeline

Primary Outcomes

Multi-Source Intelligencefrom PubMed · FDA FAERS · WHO ICTRP

Eligibility

Trial Sites (1)